Loading...
7733 logo

Olympus CorporationTSE:7733 Stock Report

Market Cap JP¥2.0t
Share Price
JP¥1.79k
My Fair Value
JP¥2k
15.6% undervalued intrinsic discount
1Y-29.5%
7D2.5%
Portfolio Value
​
View

Olympus Corporation

TSE:7733 Stock Report

Market Cap: JP¥2.0t

Olympus (7733) Stock Overview

Manufactures and sells precision machineries and instruments worldwide. More details

7733 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Rewards

Earnings are forecast to grow 7.13% per year

Earnings grew by 301.7% over the past year

Risk Analysis

Volatile share price over the past 3 months compared to the JP market


7733 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

7733 logo
Olympus

Digital Health And Emerging Markets Will Boost Minimally Invasive Endoscopy

Key Takeaways The shift to a customer-focused divisional structure and advanced product rollouts is set to drive stronger recurring revenue and increased market penetration. Olympus's focus on AI, digital health, and emerging markets supports sustained growth, leadership in endoscopy, and accelerating high-margin revenue streams.
View narrative
JP¥3.03k
FV
41.0% undervalued intrinsic discount
7.15%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
14 days ago author updated this narrative
7733 logo
Olympus

Reorganization And OLYSENSE Launch Will Improve Efficiency And Market Share

Key Takeaways Reorganization into customer-focused divisions and new product launches are set to improve efficiency, increase market penetration, and enhance revenue and margins. Local manufacturing in China and FDA clearance in the U.S. bolster market share, with initiatives like Project Elevate strengthening global medtech position.
View narrative
JP¥2.13k
FV
16.1% undervalued intrinsic discount
3.97%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
7 days ago author updated this narrative
7733 logo
Olympus

China Policies And Competitive Pressures Will Erode Operating Margins

Key Takeaways Weakness in key markets and macroeconomic pressures threaten revenue and margin stability, especially with ongoing challenges in China and developed economies. Heavy reliance on endoscopy and slow product innovation heighten technology risk, while supply chain and regulatory issues further squeeze profitability.
View narrative
JP¥1.66k
FV
7.8% overvalued intrinsic discount
2.37%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 days ago author updated this narrative
View Stock Community

Olympus Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Olympus
Historical stock prices
Current Share PriceJP¥1,789.50
52 Week HighJP¥2,867.00
52 Week LowJP¥1,443.00
Beta0.49
1 Month Change-0.084%
3 Month Change-6.80%
1 Year Change-29.51%
3 Year Change-39.45%
5 Year Change-13.13%
Change since IPO434.18%

Recent News & Updates

Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Aug 12
Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jul 25
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Recent updates

Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Aug 12
Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jul 25
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Jul 09
Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Jun 17
Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 16
Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?

Apr 22
Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?

The Returns At Olympus (TSE:7733) Aren't Growing

Apr 07
The Returns At Olympus (TSE:7733) Aren't Growing

Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects

Mar 22
Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects

These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jan 17
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
User avatar

Cloud-Powered Endoscopy Innovation Fuels Revenue Growth In The Medical Devices Industry

Approval of AI endoscopy devices in the U.S. and Europe is expected to drive revenue growth through improved clinical outcomes and procedural efficiency.

Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Nov 15
Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Nov 07
Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

Oct 12
Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Sep 27
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Shareholder Returns

7733JP Medical EquipmentJP Market
7D2.5%0.9%0.4%
1Y-29.5%-11.1%12.6%

Return vs Industry: 7733 underperformed the JP Medical Equipment industry which returned -11.1% over the past year.

Return vs Market: 7733 underperformed the JP Market which returned 12.6% over the past year.

Price Volatility

Is 7733's price volatile compared to industry and market?
7733 volatility
7733 Average Weekly Movement5.3%
Medical Equipment Industry Average Movement3.5%
Market Average Movement3.3%
10% most volatile stocks in JP Market7.5%
10% least volatile stocks in JP Market1.7%

Stable Share Price: 7733's share price has been volatile over the past 3 months compared to the JP market.

Volatility Over Time: 7733's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

FoundedEmployeesCEOWebsite
191929,297Bob Whitewww.olympus-global.com

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions, Therapeutic Solutions Others segments. The company offers gastrointestinal endoscopes, surgical endoscopes, and medical services.

Olympus Corporation Fundamentals Summary

How do Olympus's earnings and revenue compare to its market cap?
7733 fundamental statistics
Market capJP¥1.99t
Earnings (TTM)JP¥112.01b
Revenue (TTM)JP¥969.02b
17.8x
P/E Ratio
2.1x
P/S Ratio

Is 7733 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7733 income statement (TTM)
RevenueJP¥969.02b
Cost of RevenueJP¥306.40b
Gross ProfitJP¥662.62b
Other ExpensesJP¥550.62b
EarningsJP¥112.01b

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 07, 2025

Earnings per share (EPS)100.65
Gross Margin68.38%
Net Profit Margin11.56%
Debt/Equity Ratio37.8%

How did 7733 perform over the long term?

See historical performance and comparison

Dividends

1.7%
Current Dividend Yield
20%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/03 16:56
End of Day Share Price 2025/09/03 00:00
Earnings2025/06/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Olympus Corporation is covered by 30 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Warren LauAletheia Analyst Network Limited
Masahiro NakanomyoBarclays
Kunihiko KannoBNP Paribas Securities (Asia)